Trapero-Marugan M - Search Results

1

Treatment regimens for patients with chronic hepatitis C.

Trapero-Marugan M, González-Moreno L, Chaparro-Sánchez M, Moreno-Monteagudo JA, Borque MJ, Moreno-Otero R. Trapero-Marugan M, et al. Minerva Gastroenterol Dietol. 2008 Jun;54(2):209-17. Minerva Gastroenterol Dietol. 2008. PMID: 18319692 Review.

2

Combined antiviral options for the treatment of chronic hepatitis C.

Medina J, García-Buey L, Moreno-Monteagudo JA, Trapero-Marugán M, Moreno-Otero R. Medina J, et al. Antiviral Res. 2003 Oct;60(2):135-43. doi: 10.1016/j.antiviral.2003.08.009. Antiviral Res. 2003. PMID: 14638410 Review.

3

Is interferon-beta an alternative treatment for chronic hepatitis C?

Moreno-Otero R, Trapero-Marugán M, Gómez-Domínguez E, García-Buey L, Moreno-Monteagudo JA. Moreno-Otero R, et al. World J Gastroenterol. 2006 May 7;12(17):2730-6. doi: 10.3748/wjg.v12.i17.2730. World J Gastroenterol. 2006. PMID: 16718760 Free PMC article. Review.

4

[Chronic C hepatitis genotype 4].

González-Casas R, Trapero-Marugán M, Moreno-Otero R. González-Casas R, et al. Med Clin (Barc). 2011 Jun 11;137(1):31-5. doi: 10.1016/j.medcli.2010.03.022. Epub 2010 May 13. Med Clin (Barc). 2011. PMID: 20466389 Review. Spanish.

5

Long-term outcome of chronic hepatitis C patients with sustained virological response to peginterferon plus ribavirin.

Trapero-Marugán M, Mendoza J, Chaparro M, González-Moreno L, Moreno-Monteagudo JA, Borque MJ, Moreno-Otero R. Trapero-Marugán M, et al. World J Gastroenterol. 2011 Jan 28;17(4):493-8. doi: 10.3748/wjg.v17.i4.493. World J Gastroenterol. 2011. PMID: 21274379 Free PMC article.

6

[Antiviral treatment of chronic hepatitis C in interferon nonresponders].

Moreno Monteagudo JA, García Buey L, Trapero Marugán M, Moreno Otero R. Moreno Monteagudo JA, et al. Gastroenterol Hepatol. 2002 May;25(5):342-6. doi: 10.1016/s0210-5705(02)79036-5. Gastroenterol Hepatol. 2002. PMID: 11985812 Review. Spanish. No abstract available.

7

Therapeutic advantages of pegylation of interferon alpha in chronic hepatitis C.

Medina J, García Buey L, Moreno Monteagudo JA, Trapero Marugán M, Moreno Otero R. Medina J, et al. Rev Esp Enferm Dig. 2003 Aug;95(8):568-74, 561-7. Rev Esp Enferm Dig. 2003. PMID: 14510631 Review. English, Spanish.

8

Sustained virological response to peginterferon plus ribavirin in chronic hepatitis C genotype 1 patients is associated with a persistent Th1 immune response.

Trapero-Marugán M, García-Buey L, Muñoz C, Quintana NE, Moreno-Monteagudo JA, Borque MJ, Fernández MJ, Salvanés FR, Medina J, Moreno-Otero R. Trapero-Marugán M, et al. Aliment Pharmacol Ther. 2006 Jul 1;24(1):117-28. doi: 10.1111/j.1365-2036.2006.02954.x. Aliment Pharmacol Ther. 2006. PMID: 16803610

9

Clinical and pathological characteristics and response to combination therapy of genotype 4 chronic hepatitis C patients: experience from a spanish center.

Trapero-Marugan M, Moreno-Monteagudo JA, Garcia-Buey L, Borque MJ, Medina J, Garcia-Sanchez A, Moreno-Otero R. Trapero-Marugan M, et al. J Chemother. 2007 Aug;19(4):423-7. doi: 10.1179/joc.2007.19.4.423. J Chemother. 2007. PMID: 17855187

10

Predictive graphical model, network-based medical tool for the prognosis of chronic hepatitis C patients treated with peg-interferon plus ribavirin.

Trapero-Marugan M, Marin M, Pivel JP, Del Rio JM, Nunez O, Clemente G, Gisbert JP, Moreno-Otero R. Trapero-Marugan M, et al. Aliment Pharmacol Ther. 2008 Aug 15;28(4):468-74. doi: 10.1111/j.1365-2036.2008.03767.x. Epub 2008 Jun 12. Aliment Pharmacol Ther. 2008. PMID: 18549464

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters